Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00300768

Recruitment Status : Completed

First Posted : March 9, 2006

Last Update Posted : November 17, 2017

Sponsor:

Collaborator:

World Health Organization

Information provided by (Responsible Party):

Medicines Development Limited

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	November 2009
Actual Study Completion Date :	November 2009

Publications of Results:

Awadzi K, Opoku NO, Attah SK, Lazdins-Helds J, Kuesel AC. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection. PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2953. doi: 10.1371/journal.pntd.0002953. eCollection 2014 Jun.

To Top